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Abstract
Climate is one of several causes of disease emergence. Although half or more of infectious diseases are affected by
climate it appears to be a relatively infrequent cause of human disease emergence. Climate mostly affects diseases
caused by pathogens that spend part of their lifecycle outside of the host, exposed to the environment. The most
important routes of transmission of climate sensitive diseases are by arthropod (insect and tick) vectors, in water
and in food. Given the sensitivity of many diseases to climate, it is very likely that at least some will respond to
future climate change. In the case of vector-borne diseases this response will include spread to new areas. Several
vector-borne diseases have emerged in Europe in recent years; these include vivax malaria, West Nile fever, dengue
fever, Chikungunya fever, leishmaniasis, Lyme disease and tick-borne encephalitis. The vectors of these diseases are
mosquitoes, sand flies and ticks. The UK has endemic mosquito species capable of transmitting malaria and
probably other pathogens, and ticks that transmit Lyme disease. The UK is also threatened by invasive mosquito
species known to be able to transmit West Nile, dengue, chikungunya and Zika, and sand flies that spread
leishmaniasis. Warmer temperatures in the future will increase the suitability of the UK’s climate for these invasive
species, and increase the risk that they may spread disease. While much attention is on invasive species, it is
important to recognize the threat presented by native species too. Proposed actions to reduce the future impact of
emerging vector-borne diseases in the UK include insect control activity at points of entry of vehicles and certain
goods, wider surveillance for mosquitoes and sand flies, research into the threat posed by native species, increased
awareness of the medical profession of the threat posed by specific diseases, regular risk assessments, and
increased preparedness for the occurrence of a disease emergency.
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Background
There is widespread scientific agreement that anthropo-
genic activities are contributing to the warming of the
world’s climate at an unprecedented rate, with concomitant
changes in precipitation, flooding, winds and the frequency
of extreme events. Many studies have demonstrated links
between infectious diseases and climate, and it is highly
likely that changes in climate will impact on at least some
of them. This review summarises the state of scientific
evidence regarding current and future impacts of
anthropogenic climate change on the emergence of
infectious diseases with potential to impact significantly on
the UK human population. Infections are defined as ‘emer-
ging’ if they “have newly appeared in a population or have
existed previously but are rapidly increasing in incidence or
geographic range” [1]. Initially the review considers a broad
range of possible emerging infections but then narrows the
focus to vector-borne diseases.
Emerging diseases
Human diseases are affected by climate when the pathogen
spends a significant period of time outside of the human
host, subject to environmental influence. The most climate-
sensitive diseases are, therefore, those spread by arthropod
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vectors, in food or water, in aerosol, in fomites, and those
with free-living stages.
By contrast, most diseases transmitted directly between
humans (for example, human childhood viruses, sexually
transmitted diseases, tuberculosis) have few or no reported
associations with climate. Exceptions are the human
respiratory viruses, such as those that cause colds and
seasonal flu, which spread by aerosol between individuals in
close contact but are nevertheless sensitive to the effects of
ambient humidity and possibly temperature, and have
strong seasonal cycles.
Systematic reviews of disease-climate associations sup-
port these assertions. Scrutiny of research papers on 157
high-impact human and animal pathogens of Europe
found that 66% have at least one climate variable that af-
fects disease occurrence. Transmission routes of climate
sensitive diseases, in decreasing order of importance,
were vectors, food/water, environment, fomite and aero-
sol [2]. Similarly, a weighted risk analysis following sys-
tematic review identified 26 (49%) out of 53 reportable
infectious diseases of humans in Europe to be directly or
indirectly linked to climate [3].
Climate affects three major aspects of disease occur-
rence: where, when and how much. In some cases,
mostly macroparasite infections caused by helminths,
climate can also affect the severity of clinical disease in
infected individuals.
Vector-borne diseases usually have geographically-
restricted distributions because of the effects of climate of
the insects/ticks. Such diseases are particularly likely, there-
fore, to spread to new areas with climate change. Some
water-borne diseases may also spread in response to cli-
mate change, while the response of other climate-sensitive
diseases may be change to their seasonal cycles or the fre-
quency or scale of disease outbreaks in endemic regions.
Extreme weather events are an important factor in the
spread of water-borne diseases such as cholera, leptospir-
osis and gastrointestinal infections. A systematic review
[4] found that heavy rainfall and flooding frequently pre-
cede water-borne disease outbreaks. At the other extreme,
drought can lead to the concentration of water-borne
pathogens in rivers and water bodies. Temperature is also
important: higher temperatures lead to faster growth rates
of disease-causing pathogens, and increased use of bathing
waters by the public [5].
Climate change is just one of several forces (“drivers”)
that may lead to the emergence of infectious diseases.
Other drivers are changes to the environment through de-
forestation and urbanization; developments in agriculture
and food production; changes in how people live, behave,
eat, travel and trade; changes in medicine, public health
and the use of antimicrobials; and the occurrence of
“shocks” such as war, migration and famine [6]. An analysis
of more than 300 human disease outbreaks concluded that
climate and weather were infrequent causes (3%) [6]. Some
other drivers, however, such as changes to land use and
agriculture (11%), are themselves affected by climate
change. Therefore, climate change’s indirect effects on
disease emergence (via effects on other drivers) may also be
important.
There are, therefore, strong arguments to expect climate
change to impact on human disease outbreaks, especially
those transmitted by vectors or in food/water, but in prac-
tice there are relatively few examples for which there is
documented evidence. Recently, however, Europe has seen
an upsurge in vector-borne diseases, as well as the spread
of vectors, and the possible role of climate change needs
consideration.
Recent impact of climate change on vector-borne disease
emergence in Europe
The main vectors threatening or affecting the health of
people in Europe are mosquitoes, sandflies and ticks.
Malaria, caused by Plasmodium vivax and spread by the
bites of Anopheles mosquitoes, used to be endemic the
UK but there has been no transmission via native mosqui-
toes for over 60 years [7]. The disappearance of malaria is
attributed largely to changes to the environment (drainage
of marshes) and farming [7]. Similar changes have oc-
curred in mainland Europe and no areas are now endemic
for the disease. In 2009–2012, however, outbreaks of P.
vivax malaria occurred in Greece, after nearly 40 years of
only sporadic cases. This is not linked to climate change:
the origins are likely to be migrant workers introducing P.
vivax into an agricultural region where vectors were
present [8]. Nevertheless, environmental risk modelling
showed that the regions of Greece affected by malaria in
2009–2012 could be successfully predicted using digital
elevation (i.e. altitude) and satellite-derived Land Surface
Temperature variables, indicating an important role of
temperature in determining where transmission is pos-
sible, following an introduction [9].
West Nile fever, caused by West Nile virus (WNV) and
spread by Culex mosquitoes, is endemic in a number of
southern and eastern European countries. The incidence
of human cases is increasing [10]. WNV vectors are very
sensitive to changes in temperature [11], and increasing
temperature is considered to be a driver of its emergence
in Europe [12]. In the UK there have been only uncon-
firmed reports of the transmission of WNV among birds.
However, a known WNV vector, Culex modestus, was re-
cently rediscovered in southern England, after no reports
in the UK since the 1940s [13]. This re-establishment has
not been documented to be linked to climate change, but
it is interesting to note that the 1940s were the warmest
recorded period in England (Central England time series)
until the present [14].
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Indigenous UK mosquito species may present an under-
estimated risk for the transmission of arboviruses. For a
mosquito to act as a vector, it needs to live longer than the
time required for a pathogen to develop within it, and na-
tive species may be more able to survive (and hence live
longer) at the UK’s relatively cool temperatures than
exotic species. There is a good example from the field of
animal disease: bluetongue, a midge-borne viral disease of
ruminants, is transmitted in Mediterranean countries by
an invasive, African midge species. It was not foreseen
that indigenous midges could transmit bluetongue in cli-
mates as cool as southern Scandinavia. In 2006–2009, tens
of thousands of farms across northern Europe, including
some in the UK, were affected by this disease [15]. It is
noteworthy, therefore, that a UK native mosquito, Ochler-
atatus detritus, which feeds readily on humans, is a good
vector of flaviviruses, the group that includes WNV [16].
Invasive mosquitoes also present a risk of the introduc-
tion of new diseases. There have been several outbreaks of
Chikungunya fever and dengue in north Italy, southern
France and Croatia since 2007 [17–21]. The vector is the
Asian tiger mosquito, Aedes albopictus, an invasive species
that has spread from Asia to North America and Europe,
where it is now found in most southern European countries
but also Belgium and The Netherlands. The major dengue
vector, Ae. aegypti, disappeared from Europe in the mid-
twentieth century but has now returned, being found in
Madeira (an autonomous region of Portugal) in 2004–05
[22], and in the far south-east (Georgia, Abkhazia, Sochi
region of Russia) [23]. Despite vector control efforts in
Madeira, the mosquito has thrived; and in 2012 there were
more than 2000 dengue cases, the first sustained transmis-
sion of dengue in Europe since the 1920s [24].
The emergence of dengue and Chikungunya in Europe is
associated with the establishment of Ae. albopictus and Ae.
aegypti, together with mutation of Chikungunya virus that
facilitated infection of Ae. albopictus. The mosquitoes
became infected after feeding on returning travellers carrying
infections obtained overseas. The emergence is, therefore,
not directly associated with climate change although climate
has undoubtedly played an important role in determining
the geographic area where transmission is possible, and cli-
mate change may have extended that range [25].
There is a significant risk that Zika virus, which is be-
lieved to have infected over a million people in South
America in 2015–2016, will emerge in Europe in 2016 or
2017. Both Ae. aegypti and Ae. albopictus are competent
vectors [26] and the greatest risk is where these vectors are
present. Most studies find the vector competence of Ae.
aegypti for Zika virus to be higher than that of Ae. albopic-
tus and this, combined with the greater anthropophily and
biting rates of the former [27], suggests that the risk of Zika
transmission in Europe is highest where Ae. aegypti is
present (i.e. Madeira, Georgia), and lower where only Ae.
albopictus is present. There may be other mosquitoes in
UK/Europe capable of transmitting Zika virus that we are
currently unaware of. Zika virus can also be spread sexually
[28], and there is a small risk of transmission outside of
areas with competent vectors [29].
Sandflies are vectors of cutaneous and visceral leishman-
iasis in people and dogs in southern Europe. There is a low
incidence in people (~700 cases per year in southern Eur-
ope) but a high incidence in dogs (about 5000 cases per
year in France alone) [30]. Sandflies have not been detected
in the UK but have been found in central and northern
France and southern Germany [31]. The presence of known
vectors in northern Europe, and the passport-controlled
movement of potentially infected dogs into the UK [32],
raises the possibility of the eventual introduction of
leishmaniasis.
Two tick-borne diseases have emerged in Europe in recent
decades, tick-borne encephalitis (TBE) and Lyme disease,
both transmitted by the sheep tick, Ixodes ricinus. The emer-
gence of TBE is a major concern [33]. There are thousands
of cases of human disease each year, the incidence is increas-
ing, and it is spreading to new regions. Possible causes of this
emergence are socioeconomic, environmental and climatic
changes, as well as increased awareness [33, 34]. The role of
climate change on TBE emergence in the Baltics is contested
[35] and other drivers of disease emergence, such as change
in human behavior, are believed to be important factors in
this region [36].
While TBE occurs as far north as Scandinavia (indicat-
ing that the UK climate should not be a barrier to dis-
ease), and the I. ricinus vector is found throughout the
British Isles, TBE virus has not been reported in the UK.
This may be because I. ricinus transmits the related
Louping ill virus in the UK, which causes disease in
sheep and only rarely affects people.
A bacterial spirochaete disease, called Lyme borreliosis and
also spread by I. ricinus, is emerging in the UK. Lyme disease
is the most common vector-borne disease in temperate
climates, with an estimated 85,000 cases per year in Europe;
over 2000 cases occur per year in the UK alone. Lyme dis-
ease is increasing in incidence, possibly because of climate-
change influences on the tick vector. Increased I. ricinus
density and its spread to higher latitude in Sweden have been
linked to milder winters due to climate change [37].
Tick-borne disease threats also include Crimean
Congo Haemorrhagic Fever (CCHF). This viral disease is
spread largely by Hyalomma ticks, is endemic in parts of
Eastern and south-eastern Europe; and it appears to be
emerging [38]. Hyalomma ticks are not endemic to the
UK although they may arrive on migrant birds [39]; and
CCHF virus may arrive in infected travellers [40].
Most consideration has been given here to vector-
borne diseases but it is important to note that many
non-vector-borne diseases have emerged in recent years.
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Of 38 human pathogens listed by Public Health England
as having emerged (globally) since 1980, only 4 are
vector-borne. The emergence of 25 of these 38 patho-
gens is included in a study of drivers of emergence [6]
and none were attributed to climate. In other words, the
majority of emerging diseases are not vector-borne, and
their emergence is not linked to climate change.
Future impact of climate change on vector-borne disease
emergence in Europe
The World Health Organization has attempted to quantify
the additional amount of human disease that might arise
as a consequence of climate change [41, 42]. Inevitably,
there is significant uncertainty. In a recent assessment for
the years 2030 and 2050, WHO found increases of 20–
86,000 deaths globally from diarrhoeal disease of children
attributable to climate change, under a range of socioeco-
nomic growth scenarios [42]. However, the number in
Western Europe was very small (1 or 2). Equally, climate
change led to no projected deaths in Western Europe
from P. falciparum malaria or dengue.
Several other workers have developed models of climate
change’s future impacts on malaria. The most extensive
examined the projections of five malaria impact models,
each driven by five global climate models and four emis-
sion scenarios [43]. The probability of sustained malaria
transmission occurring in the UK in the current century
was found to be small, even under the most extreme emis-
sion scenario.
It is important to note, however, that all five malaria
models were developed and parameterized for malaria
caused by P. falciparum, while it was malaria from P. vivax
that was previously endemic in northern Europe, including
the UK, and which has recently reoccurred in Europe. Plas-
modium vivax transmission by European vectors requires
lower temperature thresholds than P. falciparum and,
therefore, all five malaria models and WHO’s assessments
underestimate the risk of malaria in Europe. By contrast,
under a medium-high scenario of climate change, a model
parameterized for P. vivax predicts that the southern half
of Great Britain will be climatically-suitable for P. vivax
malaria transmission by 2030 for 2 months of the year, and
parts of the southeast of England for 4 months per year
[44]; while by 2080 even southern Scotland will be
climatically-suitable for 2 months of the year [45].
The risk of malaria transmission is, however, determined
by many factors other than climate; and while climate
change may increase the suitability of the UK for transmis-
sion, other factors (such as drainage of marshes and changes
in land use) make the probability of it occurring small.
The main threat to the UK from dengue, chikungunya
and Zika viruses is tied to the risk of invasion by Ae. aegypti
and Ae. albopictus. The suitability of the current European
climate for both vectors and dengue transmission has been
modelled [46]. Much of Europe, including many parts of
the UK, were found to be suitable for Ae. albopictus;
however, few areas of Europe, and none in the UK, were
suitable for Ae. aegypti. Other workers report similar find-
ings [25]. Three models indicate that large parts of the UK
are already suitable for Ae. albopictus and predict increased
climatic suitability in future. Importantly, in autumn 2016
Ae. albopictus eggs were collected for the first time in the
UK (southern England) [47].
Arbovirus transmission requires that environmental con-
ditions are suitable for both virus and vector, and even
where vectors are present, it may be too cold for viral trans-
mission. Studies of the climatic needs of chikungunya virus
(based on conditions at past outbreaks) indicate a threshold
minimum temperature of 20–22 °C. Combining this thresh-
old with the climatic needs of the vector, the UK is found to
be climatically unsuitable for chikungunya transmission at
the present time [48] although some parts of England may
alter to become ‘rather unsuitable’ (the second lowest of five
risk classes) later in the century. No parts of the UK become
suitable for dengue virus development (in Aedes aegypti) by
2100 [49]. There is not consensus, however, Other models
of vectorial capacity find that under the most extreme emis-
sion scenarios there is a risk of transmission of dengue by
Ae. aegypti (and to a lesser extent, Ae. albopictus) during the
UK summer by 2100 [50, 51].
While there is consensus that climate affects the trans-
mission of tick-borne Lyme borreliosis, and some agree-
ment that the northward spread of the vector in Sweden
is attributable to recent warming, there are no published
models projecting its future incidence in Europe under
scenarios of climate change. Models for other temperate
regions predict that climate change will allow northern
expansion of the range of the tick vectors [52]. Lyme
and its vectors are already found throughout the UK
and, therefore, increasing climate suitability may be lim-
ited to increase in altitude [53] and change in incidence.
Non-climate drivers, however, play a dominant role in
the epidemiology of Lyme disease [54] and future trends
in agriculture, land use, wild animal populations and
tourism will play a large role in determining future pat-
terns of the disease [55].
Potential for impacts to be avoided by adaptation measures
Adaptation to the risk of emerging infections requires
three actions: (i) improved surveillance of disease and,
where appropriate, vectors, so that sporadic cases and
outbreaks, or the heightened risk of these, can be
detected early; (ii) risk assessments of the likelihood of
cases or outbreaks of an emerging disease, regularly up-
dated as new data become available, including forecasts
based on vector, disease, climate and sociodemographic
and travel/transport data; and (iii) increased prepared-
ness for outbreaks.
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The northward spread of Ae. albopictus indicates the
need for active surveillance for invasive mosquitoes. There
is strong evidence that some of the spread of Ae. albopic-
tus in continental Europe is associated with transport in
vehicles as, for example, it has been trapped in motorway
service areas. The extensive movement of cars and goods
vehicles into the UK from continental Europe should be
considered a likely route of entry of this mosquito. Insecti-
cidal treatment of vehicles entering the UK could help to
reduce this risk. ‘Disinsection’, as described by the Inter-
national Health Regulations of the WHO, is already used
to kill insects in airplanes arriving in certain countries.
Aedes albopictus has also entered many countries in used
vehicle tyres or in ‘lucky bamboo’, a houseplant imported
from China. Mosquito surveillance at ports of entry of
such products is recommended.
A known vector of West Nile virus, Culex modestus,
has re-established in the UK. Surveillance within affected
regions can help identify areas of particular risk of virus
transmission; and surveillance outside such areas can be
used to monitor its further spread.
Adaptation measures to Lyme disease include increas-
ing awareness of the public, in terms of recognizing
symptoms and taking tick-avoidance measures; and im-
proving national-level surveillance. For surveillance, it
has been recommended to base the clinical definition of
Lyme disease on the skin rash that occurs in about 90%
of cases, rather than on the rare Lyme neuroborreliosis
that needs laboratory confirmation [3]. Forecasts of the
risk of exposure to tick vectors or Lyme, based on geo-
graphic and climatic information, will help the public to
take suitable precautions.
The risk of emerging disease outbreaks in the UK, par-
ticularly vector-borne, food-borne and water-borne dis-
eases, is likely to continue to rise as our climate changes.
New data will frequently become available, such as up-
dated maps of the occurrence of potentially invasive vec-
tors in continental Europe. Risk assessments should,
therefore, be regularly updated.
Preparedness for outbreaks of vector-borne diseases re-
quires (i) knowledge of the vectors, (ii) identification of
areas of high risk, (iii) in such areas, raised awareness of
the public and health professionals and (iv) development
of policy and approval of legislation to permit vector con-
trol programmes. A contingency plan should be developed
for the event that Ae. albopictus is detected in the UK.
Conclusions
Given the sensitivity of many diseases to climate, it is very
likely that at least some will respond to future climate
change. Many water-borne and food-borne diseases are cli-
mate sensitive but there is a relative paucity of published
studies on the impacts of climate change upon them. The
impact of climate change on infectious respiratory diseases
requires further study, as such diseases can spread rapidly
and cause significant health impact; detailed studies of the
impacts of climate change on them, however, has received
little attention [56].
This review has focused extensively on vector-borne dis-
eases because they are particularly climate-sensitive. Several
vector-borne diseases have recently emerged in Europe, and
some threaten the UK. The greatest risk is probably pre-
sented by West Nile virus, as is widespread in southern and
Eastern Europe and the UK harbours at least one competent
vector species. There is a threat of invasion by the Asian
Tiger mosquito, Ae. albopictus; if the vector enters and sur-
vives in the UK, however, it may be too cold for sustained
transmission of dengue, chikungunya or Zika viruses. The
UK is, and long has been, climatically suitable for the trans-
mission of malaria caused by P. vivax. Climate change will
increase the climatic suitability even further, but this is
unlikely to lead to sustained malaria transmission if land use
and agricultural practices remain as they are today. How-
ever, the recreation of extensive wetlands and salt marshes,
combined with warmer temperatures, may create a situation
where local vivax malaria transmission is possible.
The emergence of Lyme disease in the UK is likely to
continue in the future. Climate change may contribute
to this emergence, but other drivers will probably play a
larger role. The risk presented by TBE, which is emer-
ging in many parts of Europe, remains difficult to gauge.
Key research gaps are: (i) assessment of the impact of
climate change on diseases that are not vector-borne, in-
cluding respiratory infections; (ii) evaluation of the vector
potential of UK native species; (iii) development of climate
driven models for the risk of West Nile and Lyme in the
UK; (iv) evaluation of the threat posed by TBE to the UK
and (v) incorporation of environmental, agricultural and
sociodemographic variables into models of the risk of vivax
malaria in the UK.
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